Details of the Active Pharmaceutical Ingredient (API)
| General Information of API (ID: D00741) | |||||
|---|---|---|---|---|---|
| Name |
Zinc acetate
|
||||
| Synonyms |
Click to Show/Hide the Synonyms of This API
ZINC ACETATE; Zinc diacetate; 557-34-6; Zinc(II) acetate; Acetic acid, zinc salt; Dicarbomethoxyzinc; Zinc acetate anhydrous; Acetic acid, zinc(II) salt; Zinc di(acetate); zinc;diacetate; Zn(OAc)2; UNII-H2ZEY72PME; Acetic acid, zinc salt (2:1); H2ZEY72PME; CHEBI:62984; Zinc acetate, 99%, pure; Siltex CL 4; CCRIS 3471; MFCD00012454; NSC-75801; HSDB 1043; EINECS 209-170-2; NSC 75801; AI3-04465; zinc (II) acetate; zinc acetate carrageenan; ACMC-20aj8v; Zn(II)Ac2; SCHEMBL51; ZINC ACETATE BASIC; C4H6O4Zn; Zinc Acetate 35% 40M; (CH3CO2)2Zn; DSSTox_CID_18770; DSSTox_RID_79392; DSSTox_GSID_38770; NPC-02; CHEMBL1200928; DTXSID8038770; Zinc Acetate, Trace metals grade; Tox21_302016; AKOS015837576; DB14487; NCGC00255475-01; 82279-57-0; CAS-557-34-6; CS-0013863; FT-0689089; Q204639
|
||||
| Clinical Status |
Approved
|
||||
| Disease Indication | Hyperphosphatemia | ICD-11: 5C64 | [1] | ||
| PubChem CID | |||||
| Formula |
C4H6O4Zn
|
||||
| Canonical SMILES |
CC(=O)[O-].CC(=O)[O-].[Zn+2]
|
||||
| InChI |
1S/2C2H4O2.Zn/c2*1-2(3)4;/h2*1H3,(H,3,4);/q;;+2/p-2
|
||||
| InChIKey |
DJWUNCQRNNEAKC-UHFFFAOYSA-L
|
||||
| Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=11192"></iframe>
|
![]() |
|||
| 3D MOL is unavailable | 2D MOL | ||||
| Physicochemical Properties | Molecular Weight | 183.5 | Topological Polar Surface Area | 80.3 | |
| XlogP | N.A. | Complexity | 25.5 | ||
| Heavy Atom Count | 9 | Rotatable Bond Count | 0 | ||
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 4 | ||
| Full List of Drug Formulations (DFMs) Containing This API | ||||||
|---|---|---|---|---|---|---|
| Zinc acetate 50 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; D&c red no. 28; D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Propylparaben; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin, unspecified; Shellac; Starch, corn
|
|||||
| Dosage Form | Oral Capsule | |||||
| Company | Teva Select Brands | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
| methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [4] | |||
| FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
| D&C red no. 28 | DIG Info | Organic anion transporter 1 (Ki = 0.064 uM) | [2] | |||
| Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
| Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [2] | |||
| Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
| Zinc acetate 25 mg capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
| Drug Formulation 1 |
DFM Info
click to show the detail info of this DFM
|
|||||
| All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
D&c yellow no. 10; Fd&c red no. 40; Fd&c blue no. 1; Fd&c blue no. 2; Indigotindisulfonate sodium; Magnesium stearate; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Gelatin, unspecified; Shellac; Starch, corn
|
|||||
| Dosage Form | Oral Capsule | |||||
| Company | Teva Select Brands | |||||
| DIG(s) with Biological Activity | ||||||
| DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
| FD&C blue no. 1 | DIG Info | Solute carrier SLCO2B1 (Ki = 13 uM) | [3] | |||
| FD&C blue no. 2 | DIG Info | Adenosine receptor A3 (IC50 = 1 uM) | [2] | |||
| Quinoline yellow WS | DIG Info | Estrogen receptor alpha (IC50 = 18 uM) | [2] | |||
| Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [3] | |||
| Propylene glycol | DIG Info | Albendazole monooxygenase (Inhibition ratio < 20 %) | [5] | |||
| Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [6] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.


